Cancer Channel
Topics
Medications
Quicklinks
Related Channels

Kyprolis

When and How to Use It

Some general considerations to keep in mind during treatment with Kyprolis include the following:
 
  • This medication comes as a powder that is dissolved in liquid and given as an injection into a vein (an intravenous, or IV, injection). It is normally given once a day for two consecutive days each week.
 
  • After three weeks, you will receive a break in treatment when no doses are given.
 
  • Kyprolis injections are normally given by a healthcare provider in a healthcare setting, such as a hospital or infusion clinic.
 
  • The actual dose is given over 2 to 10 minutes.
 
  • Your healthcare provider may give you other medicines to help reduce the risk for certain Kyprolis side effects.
 
  • It is important to stay hydrated during treatment to help maintain adequate kidney function. Your healthcare provider may give you IV fluids before and after your doses. Ask your healthcare provider how much fluid you should consume each day.
 
  • For Kyprolis to work properly, it must be used as prescribed. This medication works best if taken on schedule. However, you may need to miss doses due to side effects.  
 

Dosing Information

The dose of Kyprolis your healthcare provider recommends will vary, based on a number of factors, such as:
 
  • Your height and weight
  • How well you tolerate the medication.
 
As is always the case, do not adjust your dosage unless your healthcare provider specifically tells you to do so.
 
(Click Kyprolis Dosage for more information.)
 
The Zen of Cancer Caregiving - Recharge Your Batteries!

Kyprolis Chemotherapy Information

Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2017 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.